HomeEXECUTIVES
EXECUTIVES
The medical device news magazine is the latest source for industry scoop. In this article, we take a look at which executives are on the move.
As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.
Charles Simonton, M.D. Has Been Appointed New CMO of Abiomed
Charles Simonton, M.D. is renowned for his leadership in product development and large-scale clinical trials. He was most recently at Abbott Vascular where he served as chief medical officer and divisional vice president of Global Medical Affairs since 2008.
Anthony Bihl Joins Sonendo® Board of Directors
Anthony Bihl has extensive experience in a variety of leadership roles in the global medical device industry, in both private and public companies. Until his retirement in April 2020, he served as Chief Executive Officer for Bioventus, LLC.
Bigfoot Biomedical Names Recognized Endocrinologist and Clinical Researcher Dr. Jim Malone as CMO
Dr. Malone, an endocrinologist specializing in diabetes, spent 12 years in clinical practice and 21 years in clinical research, where he developed diabetes products and delivery devices at Eli Lilly & Company
Phillip L. McStotts, CPA, CGMA Appointed to Titan Medical Board of Directors
Phillip L. McStotts is a financial expert with Certified Public Accountant and Certified Global Management Accountant credentials, Mr. McStotts will also be a member of the Audit Committee of the Board of Directors.
Precision OS Announces Professor Richard Satava as Key Simulation Advisor
In his role Dr. Satava will provide his wealth of experience in simulation, research and surgical expertise toward the development of enhanced immersive training and education modules created by Precision OS.
Donald L Deyo Appointed Chairman and Head of US Operations at LindaCare
Donald L. Deyo is a medtech veteran with extensive experience in development and commercialization of cardiac disease therapies. In the new roles he will guide acceleration of growth in the US and strategic expansion into areas adjacent to and leveraging the Company's flagship OnePulse™ remote monitoring platform.
Scott Davie Appointed TriSalus Chief Technology Officer
Prior to joining TriSalus Life Sciences, Scott Davie held a number of leadership positions at Medtronic creating and leading teams and engineering departments.
numares Announces Winton Gibbons as New President of US Subsidiary
numares highlights Winton Gibbons will further strengthen commercialization of numares’ products, and help expand the existing network of collaboration partners and investors.
BioMarker Strategies Names Greg Bertenshaw Chief Operating and Science Officer
Dr. Bertenshaw, formerly Vice President, Research & Development, will continue to report directly to Jerry Parrott, President and Chief Executive Officer.
